Two groups derived neural and mesodermal cells from human fibroblasts by going through a partially reprogrammed intermediate.
Subject terms:
- Stem Cells
- Cell Biology
- Genetics
The ability to easily convert accessible human cells into disease-relevant cell types through cellular reprogramming has opened new doors for basic research and regenerative medicine1. Takahashi and Yamanaka ushered in contemporary reprogramming when they demonstrated that a combination of four transcription factors (Oct3/4, Sox2, Klf4 and c-Myc) could drive skin-derived fibroblasts to a pluripotent state that could be further differentiated into the desired cell type2 (Fig. 1a). But robust differentiation into specific lineages remains a stumbling block. Low efficiencies and week- to month-long protocols often give rise to mixed cultures requiring a second purification step. Purity matters, as remnant pluripotent cells can give rise to tumors after transplantation. Moreover, the yielded cells are typically immature (as in cardiomyocyte, hematopoietic or neuronal differentiation).
No comments:
Post a Comment